William Blair Reiterates “Market Perform” Rating for Kezar Life Sciences (NASDAQ:KZR)
William Blair reaffirmed their market perform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research note published on Wednesday morning,RTT News reports. Separately, HC Wainwright reissued a “neutral” rating on shares of Kezar Life Sciences in a research report on Monday, October 14th. Check Out Our Latest Stock Analysis on […]
More Stories
Walt Disney (NYSE:DIS) Price Target Raised to $130.00
Walt Disney (NYSE:DIS – Free Report) had its price target increased by Guggenheim from $110.00 to $130.00 in a report...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Update
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) saw a significant growth in short interest during the month of October....
South Street Advisors LLC Trims Stock Position in RTX Co. (NYSE:RTX)
South Street Advisors LLC cut its stake in shares of RTX Co. (NYSE:RTX – Free Report) by 7.5% in the...
Kulicke and Soffa Industries (NASDAQ:KLIC) Raised to “Buy” at Needham & Company LLC
Needham & Company LLC upgraded shares of Kulicke and Soffa Industries (NASDAQ:KLIC – Free Report) from a hold rating to...
Maxwell Wealth Strategies Inc. Grows Position in Tesla, Inc. (NASDAQ:TSLA)
Maxwell Wealth Strategies Inc. lifted its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 580.1% in the...
9,068 Shares in Pfizer Inc. (NYSE:PFE) Bought by Turtle Creek Wealth Advisors LLC
Turtle Creek Wealth Advisors LLC bought a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the 3rd quarter,...